Abstract
The heart is the first organ to form during development in vertebrates, and many organs start to develop adjacent to the cardiovascular system. Endothelial cells (ECs) form the inner cell lining of blood vessels and represent the major cell type that interacts with developing organs including the pancreas. ECs receive signals from the developing pancreas to grow and, at the same time, release signals to determine cell-fate specification, morphogenesis and function of the pancreas. In addition to promoting survival of pancreatic islets, in this review, we discuss the role of the vascular niche and angiogenic factors, particularly VEGFA, during pancreatic beta cell development, regeneration and pathophysiological progression of diabetes. Nevertheless, unraveling the molecular signals involved in pancreatic beta cell development and regeneration may shed light into novel drug development to treat diabetes.
Keywords: Angiogenesis, autoimmunity, diabetes, pancreatic beta cells, regeneration.
Current Stem Cell Research & Therapy
Title:VEGF-A: The Inductive Angiogenic Factor for Development, Regeneration and Function of Pancreatic Beta Cells
Volume: 9 Issue: 5
Author(s): Kathy O. Lui
Affiliation:
Keywords: Angiogenesis, autoimmunity, diabetes, pancreatic beta cells, regeneration.
Abstract: The heart is the first organ to form during development in vertebrates, and many organs start to develop adjacent to the cardiovascular system. Endothelial cells (ECs) form the inner cell lining of blood vessels and represent the major cell type that interacts with developing organs including the pancreas. ECs receive signals from the developing pancreas to grow and, at the same time, release signals to determine cell-fate specification, morphogenesis and function of the pancreas. In addition to promoting survival of pancreatic islets, in this review, we discuss the role of the vascular niche and angiogenic factors, particularly VEGFA, during pancreatic beta cell development, regeneration and pathophysiological progression of diabetes. Nevertheless, unraveling the molecular signals involved in pancreatic beta cell development and regeneration may shed light into novel drug development to treat diabetes.
Export Options
About this article
Cite this article as:
Lui O. Kathy, VEGF-A: The Inductive Angiogenic Factor for Development, Regeneration and Function of Pancreatic Beta Cells, Current Stem Cell Research & Therapy 2014; 9 (5) . https://dx.doi.org/10.2174/1574888X09666140710100603
DOI https://dx.doi.org/10.2174/1574888X09666140710100603 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Systematic Evaluation of the Mechanisms of Mulberry Leaf (Morus alba Linne) Acting on Diabetes Based on Network Pharmacology and Molecular Docking
Combinatorial Chemistry & High Throughput Screening The Anti-Atherogenic Effects of Thiazolidinediones
Current Diabetes Reviews Lipid Management and Peripheral Arterial Disease
Current Drug Targets Role of Advanced Glycation End Products (AGEs) in Osteoporosis in Diabetes
Current Drug Targets Vaccines For Type 1 Diabetes: Prevention or Reversal?
Current Diabetes Reviews Molecular Mechanisms, Proteinopathies and Therapeutic Strategies in Neurodegenerative Disorders
Current Genomics An Overview of Phytochemical and Pharmacological Profile of <i>Morus alba</i> Linn
Current Bioactive Compounds A Therapeutic Target for Microvascular Complications in Diabetes: Endothelium- Derived Hyperpolarizing Factor
Current Cardiology Reviews Advanced Diabetes Care: Three Levels of Prediction, Prevention & Personalized Treatment
Current Diabetes Reviews Calorie Restriction and Dietary Restriction Mimetics: A Strategy for Improving Healthy Aging and Longevity
Current Pharmaceutical Design Editorial (Thematic Issue: Medicinal Chemistry: Neurological and Endocrinological Disorders)
Medicinal Chemistry Case Series Describing an Outbreak of Highly Resistant Vancomycin Staphylococcus aureus (Possible VISA/VRSA) Infections in Orthopedic Related Procedures in Guatemala
Infectious Disorders - Drug Targets Malnutrition in Patients with End-Stage Renal Disease - Anorexia,Cachexia and Catabolism
Current Nutrition & Food Science Diabetes and Chronic Heart Failure: From Diabetic Cardiomyopathy to Therapeutic Approach
Endocrine, Metabolic & Immune Disorders - Drug Targets Hypothyroidism and Nephrotic Syndrome: Why, When and How to Treat
Current Vascular Pharmacology Transcriptional and Non-transcriptional Regulation of Glucose Metabolism and Insulin Sensitivity through Vitamin D
Current Nutrition & Food Science A Very Rare Cerebral Complication of Chemotherapy in a Young Girl: A Difficult Diagnosis
Current Drug Safety Anti-Inflammatory Treatments for Chronic Diseases: A Review
Inflammation & Allergy - Drug Targets (Discontinued) Endothelial Dysfunction and Platelet Hyperaggregation in Type 2 Diabetes Mellitus: The Era of Novel Anti-diabetic Agents
Current Medicinal Chemistry Exploring AT2R and its Polymorphism in Different Diseases: An Approach to Develop AT2R as a Drug Target beyond Hypertension
Current Drug Targets